Increased Demand for Medical and Security Technologies at Dräger Corporation
In the heart of Lübeck, Germany, the story of Dräger AG & Co. KGaA began in 1889 with the invention of a valve for beer tapping systems by Johann Heinrich Dräger. Since then, the family-owned company has grown exponentially, becoming a global leader in medical and safety technology.
Today, Dräger is a multinational corporation, employing over 16,000 people in over 190 countries. The company's success is driven by a strong focus on innovation, with notable inventions including the world's first ventilator in 1907 and the anesthesia apparatus.
Dräger's commitment to research and development is evident in its significant investments. Last year, the company invested around 330 million euros, with plans to increase this to up to 350 million euros by 2025. This investment is being utilised in ongoing research, such as the use of AI for processing biomedical signals, which is being carried out at the University of Lübeck.
The company's growth is also influenced by long-term growth factors, such as demographic change and increasing safety regulations for industrial companies. This has led to an increase in order intake, with Drägerwerk AG & Co. KGaA seeing a 134 million euro increase in the first half of 2025, reaching 1.738 billion euros.
Dräger's Medical Technology segment, which includes ventilators and anesthesia devices, experienced a 14.8% year-on-year increase in order intake. The company serves diverse sectors including hospitals, industry, and fire departments worldwide with its medical and safety technology products. However, the largest customer of Drägerwerk AG & Co. KGaA is not explicitly stated in the available information.
Lübeck harbor is also undergoing digitization, aiming for a better overview. This digitization, combined with Dräger's focus on AI, is expected to further drive the company's growth.
Looking ahead, Dräger is set to host its fifth Hackathon in October, involving students from various fields collaborating on questions related to artificial intelligence. This event underscores Dräger's commitment to fostering innovation and collaboration, key drivers in the company's century-long success story.
For more information about Dräger and its products, visit www.draeger.com.
Read also:
- visionary women of WearCheck spearheading technological advancements and catalyzing transformations
- Recognition of Exceptional Patient Care: Top Staff Honored by Medical Center Board
- A continuous command instructing an entity to halts all actions, repeated numerous times.
- Oxidative Stress in Sperm Abnormalities: Impact of Reactive Oxygen Species (ROS) on Sperm Harm